Novartis to cut US jobs on Rasilez Ph III failure and Diovan patent loss
Swiss drug major Novartis has announced plans to cut US jobs and predicts a challenging couple of years for its pharma division.
Archives for January 16, 2012
China wants vaccine production innovation to boost local sector
The Chinese government is encouraging development of new vaccine production processes in a bid to achieve self-reliance.
FDA plans overseas inspections as GDUFA goes to Congress
The US FDA has sent its generic user fee recommendations to Congress ahead of a meeting to discuss the plan next month.
UPDATE
New RNA delivery platform could improve aptamer internalisation, say researchers
A new discovery platform for RNA delivery vehicles could mean 20 per cent more efficiency for guiding nanoparticles into cancer cells, say researchers.
Covance unveils further, ‘substantial' IT investment at JP Morgan conf
Covance plans a ‘substantial investment’ to consolidate its international data centres and develop clinical tools to arrest expanding IT costs.
Popsi Cube using iPhones for blood pressure data tracking
CRO Popsi Cube is using iPhones to track blood pressure data and send questionnaires to patients.
Contract manufacturing news round-up
Outsourcing-Pharma presents a round-up of the latest contract manufacturing headlines in the industry, including news from Nanohale, Fleming and Trophogen.
Warnex will be forced to leave Toronto exchange next month
Contract services firm Warnex will leave the Toronto Stock Exchange (TSX) after failing to meet the requirements for continued listing.